Cannabics Pharmaceuticals (CNBX.OTC) announced that its recent tests have shown that the cannabinoids CBC (cannabichromene) and CBD (cannabigerol) both exhibit anti-tumour properties when tested on human gastrointestinal cancer cells….
Research
Sick of hearing about how cannabis companies are ‘on the cusp of something great’ and ‘leading the industry’? Well Experion’s new CEO has gone another way: Truth….
On December 17, 2019 Isracann (IPOT.C) announced that it has entered into an Memorandum of Understanding (MOU) for a joint venture (JV) with an additional cannabis farm property in…
On December 5, 2019 CLS Holdings (CLSH.C) announced that it has completed the buildout and licensing for phase 1 of its north Las Vegas processing facility. The CLS business…
On January 10, 2018 (almost two years ago), the Canadian Marijuana Index peaked just north of a 1,000. At that time, the valuation of almost every cannabis company looked…
On December 2, 2019 Sol Global (SOL.C) released its Q2, financial results for the three and six-month period ended September 30, 2019. SOL Global invests in cannabis related companies…
Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…
Perusing Pivot Pharmaceuticals’ (PVOT.C) website you might think you’ve stumbled onto Pfizer’s (PFE.NYSE) “Proprietary IP” link. “RTIC infused substrates”? “Supercritical extraction”? “Phospholipid bilayers”? Anyone? In fact, if you strip…
Yield Growth (BOSS.C) partnered with Peak Performance Products to act as their Canadian distributor for their Urban Juve line of hemp products today. The agreement gives Peak Performance the…
I have never tried opium. But I suspect I would like it. Derived from the milky sap of the poppy, the Greek poet Homer (800 BC) referred to it…